跳至主要内容
临床试验/ISRCTN10372301
ISRCTN10372301已完成不适用

Artemether in the treatment of Fasciola hepatica and/or Fasciola gigantica infections in Egypt: an open-label non-randomised proof of concept trial

Swiss Tropical Institute (Switzerland)0 个研究点目标入组 40 人开始时间: 2009年3月30日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Both males and females, age 11-70 years
  • 2. For married females, not pregnant, as assessed by the medical doctor last menstrual cycle, upon initial clinical assessment
  • 3. Absence of major systemic illnesses, as assessed by the medical doctor, upon initial clinical assessment
  • 4. Infection with F. hepatica and/or F. gigantica as confirmed by standard parasitological stool examination
  • 5. No known or reported hypersensitivity to artemether
  • 6. No known or reported history of chronical illness such as cancer, diabetes, hypertension, chronic heart, liver or renal disease
  • 7. Full clinical examination
  • 8. Written informed consent

排除标准

  • 1. Presence of any abnormal medical condition, judged by the medical doctor. If several patients experience serious adverse events the study will be stopped.
  • 2. Severe liver disease of other aetiology
  • 3. Recent history of anthelminthic drugs (triclabendazole, albendazole, bithionol, dehydroemetine, praziquantel within past 4 weeks)
  • 4. Attending other clinical trials during the study
  • 5. For females: pregnancy, lactation

研究者

发起方
Swiss Tropical Institute (Switzerland)

相似试验